Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 15.26
-0.32 (-2.05%)
Jul 24, 2026, 5:29 PM CET
Xspray Pharma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.07 | 6.43 | 2.1 | 31.77 | 2.18 | 0.66 | |
Revenue Growth (YoY) | 30.46% | 206.87% | -93.40% | 1357.20% | 232.32% | -51.91% |
Gross Profit | 5.07 | 6.43 | 2.1 | 31.77 | 2.18 | 0.66 |
Selling, General & Admin | 145.08 | 151.1 | 203.88 | 169.57 | 109.6 | 58.38 |
Research & Development | 7.95 | 10.75 | 79.36 | 40.26 | 22.22 | 38.57 |
Other Operating Expenses | 1.15 | 1.49 | 5.9 | 3.68 | 3.43 | 1.66 |
Total Operating Expenses | 154.18 | 163.34 | 289.14 | 213.5 | 135.25 | 98.61 |
Operating Income | -149.12 | -156.91 | -287.04 | -181.73 | -133.07 | -97.95 |
Interest Income | 1.83 | 2.22 | 3.3 | 2.73 | 1.42 | 1.26 |
Interest Expense | -17.32 | -16.85 | -1.93 | -0.68 | -0.01 | -0 |
Total Non-Operating Income (Expense) | -15.49 | -14.64 | 1.37 | 2.05 | 1.4 | 1.26 |
Pretax Income | -164.61 | -171.55 | -285.67 | -179.68 | -131.67 | -96.7 |
Provision for Income Taxes | 0.09 | 0.1 | 0.15 | 0.02 | - | - |
Net Income | -164.7 | -171.65 | -285.83 | -179.7 | -131.67 | -96.7 |
Net Income to Common | -164.52 | -171.44 | -285.52 | -179.67 | -131.67 | -96.7 |
Shares Outstanding (Basic) | 40 | 38 | 33 | 27 | 21 | 19 |
Shares Outstanding (Diluted) | 40 | 38 | 33 | 27 | 21 | 19 |
Shares Change (YoY) | 14.43% | 16.04% | 24.61% | 26.21% | 9.53% | 8.81% |
EPS (Basic) | -5.34 | -4.46 | -8.62 | -6.76 | -6.25 | -5.03 |
EPS (Diluted) | -5.34 | -4.46 | -8.62 | -6.76 | -6.25 | -5.03 |
Free Cash Flow | -157.51 | -193.16 | -226.75 | -205.97 | -134.65 | -52.92 |
Free Cash Flow Per Share | -3.98 | -5.02 | -6.84 | -7.74 | -6.39 | -2.75 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -2942.87% | -2439.52% | -13694.70% | -572.08% | -6104.27% | -14931.90% |
Profit Margin | -3250.38% | -2668.69% | -13636.70% | -565.69% | -6039.91% | -14740.50% |
FCF Margin | -3108.57% | -3003.16% | -10818.10% | -648.37% | -6176.38% | -8067.07% |
EBITDA | -143.56 | -151.33 | -278.49 | -172.54 | -123.54 | -89.08 |
EBITDA Margin | -2833.31% | -2352.78% | -13286.90% | -543.14% | -5666.97% | -13579.70% |
EBIT | -149.12 | -156.91 | -287.04 | -181.73 | -133.07 | -97.95 |
EBIT Margin | -2942.87% | -2439.52% | -13694.70% | -572.08% | -6104.27% | -14931.90% |
Effective Tax Rate | -0.06% | -0.06% | -0.05% | -0.01% | 0.00% | 0.00% |